Drugs in Dev.
Gastroenterology
Undisclosed
United States Of America 
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Multivitamin
Therapeutic Area : Gastroenterology
Study Phase : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Multivitamin + Probiotic Effect On Gut Health In GLP-1 Users
Details : Multivitamin is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in clinical studies for the treatment of Irritable Bowel Syndrome.
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
August 19, 2025
Lead Product(s) : Multivitamin
Therapeutic Area : Gastroenterology
Highest Development Status : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Huo Ma Ren Extract
Therapeutic Area : Gastroenterology
Study Phase : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
A Study of Herbal Supplements in Cancer Survivors with Constipation
Details : Huo Ma Ren Extract is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of Constipation.
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
July 29, 2025
Lead Product(s) : Huo Ma Ren Extract
Therapeutic Area : Gastroenterology
Highest Development Status : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Enzyme Cocktail A
Therapeutic Area : Gastroenterology
Study Phase : Undisclosed
Sponsor : University of North Texas, Denton, TX
Deal Size : Inapplicable
Deal Type : Inapplicable
Efficacy of Two Enzyme Cocktails in Healthy Adults
Details : Enzyme Cocktail A is a Enzyme drug candidate, which is currently being evaluated in clinical studies for the treatment of Digestive System Diseases.
Product Name : Undisclosed
Product Type : Enzyme
Upfront Cash : Inapplicable
November 29, 2024
Lead Product(s) : Enzyme Cocktail A
Therapeutic Area : Gastroenterology
Highest Development Status : Undisclosed
Sponsor : University of North Texas, Denton, TX
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : INF108
Therapeutic Area : Gastroenterology
Study Phase : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Infinant Health Announces Submission of Orphan Drug Designation Application
Details : Infinant Health's patented drug candidate is a Bifidobacterium longum subspecies infantis strain, INF108, being developed for the prevention of necrotizing enterocolitis in pre-term infants.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
April 02, 2024
Lead Product(s) : INF108
Therapeutic Area : Gastroenterology
Highest Development Status : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Ensure Surgery Immunonutrition
Therapeutic Area : Gastroenterology
Study Phase : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Pre-operative Nutrition for Elective Resection Surgery in Inflammatory Bowel Disease
Details : Ensure Surgery Immunonutrition is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Inflammatory Bowel Diseases.
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
March 13, 2024
Lead Product(s) : Ensure Surgery Immunonutrition
Therapeutic Area : Gastroenterology
Highest Development Status : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Probiotic
Therapeutic Area : Gastroenterology
Study Phase : Undisclosed
Sponsor : Analyze & Realize
Deal Size : Inapplicable
Deal Type : Inapplicable
The Efficacy of a Probiotic for Functional Constipation (FC)
Details : This is a Probiotic drug candidate, which is currently being evaluated in clinical studies for the treatment of Constipation.
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
October 16, 2023
Lead Product(s) : Probiotic
Therapeutic Area : Gastroenterology
Highest Development Status : Undisclosed
Sponsor : Analyze & Realize
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Probiotic
Therapeutic Area : Gastroenterology
Study Phase : Undisclosed
Sponsor : Analyze & Realize
Deal Size : Inapplicable
Deal Type : Inapplicable
The Efficacy of a Probiotic for Antibiotic Associated Gastrointestinal Symptoms
Details : This is a Probiotic drug candidate, which is currently being evaluated in clinical studies for the treatment of Diarrhea.
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
May 06, 2023
Lead Product(s) : Probiotic
Therapeutic Area : Gastroenterology
Highest Development Status : Undisclosed
Sponsor : Analyze & Realize
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Probiotic
Therapeutic Area : Gastroenterology
Study Phase : Undisclosed
Sponsor : Vizera d.o.o.
Deal Size : Inapplicable
Deal Type : Inapplicable
Safety and Efficacy of a Probiotic Supplement in IBS-D
Details : This is a Probiotic drug candidate, which is currently being evaluated in clinical studies for the treatment of Irritable Bowel Syndrome.
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
March 03, 2023
Lead Product(s) : Probiotic
Therapeutic Area : Gastroenterology
Highest Development Status : Undisclosed
Sponsor : Vizera d.o.o.
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Rifaximin
Therapeutic Area : Gastroenterology
Study Phase : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : XIFAXAN (rifaximin) is a 2 week prescription treatment that provided up to 6 months of relief from IBS-D symptoms of abdominal pain and diarrhea in a clinical trial.
Product Name : Xifaxan-Generic
Product Type : Antibiotic
Upfront Cash : Inapplicable
August 11, 2022
Lead Product(s) : Rifaximin
Therapeutic Area : Gastroenterology
Highest Development Status : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Probiotic
Therapeutic Area : Gastroenterology
Study Phase : Undisclosed
Sponsor : Atlantia Food Clinical Trials | Vedic Lifesciences Pvt. Ltd.
Deal Size : Inapplicable
Deal Type : Inapplicable
Study to Evaluate the Efficacy of a Probiotic in Infantile Colic Symptoms Relief
Details : This is a Probiotic drug candidate, which is currently being evaluated in clinical studies for the treatment of Colic.
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
June 27, 2022
Lead Product(s) : Probiotic
Therapeutic Area : Gastroenterology
Highest Development Status : Undisclosed
Sponsor : Atlantia Food Clinical Trials | Vedic Lifesciences Pvt. Ltd.
Deal Size : Inapplicable
Deal Type : Inapplicable
